HomeNewsIndustrial talks

Vivek Sehgal appointed as new DG of OPPI

Vivek Sehgal appointed as new DG of OPPI

The Organisation of Pharmaceutical Producers of India (OPPI), which represents the research-based pharmaceutical companies, has appointed Vivek Sehgal as its new Director-General. Sehgal takes over from KG Ananthakrishnan who has been with OPPI since 2020. 

Sehgal has close to three decades of cross-sectoral experience on policy issues with central/state governments, regulators, and other key stakeholders. In his most recent role, he was the Assistant Secretary-General, PHD Chamber of Commerce & Industry where he handled varied sectors including - Health, AYUSH, Defense and Homeland Security, Capital and Commodity Markets, Corporate Affairs, and Direct Selling. His work on policy advocacy in sectors like health, AYUSH, IT, and defence has been significantly successful in its acceptance by the concerned ministries. 

Commenting on the development, S Sridhar, President,OPPI said, “Sehgal comes with a rich, deep, and diverse background. His experience has been in shaping policy issues with central/state governments, regulators and other key stakeholders and positioning the Chamber in international bodies like World Bank, WHO SEARO, and WHO India. I am confident that under his able leadership and detailed subject matter knowledge, OPPI will be able to achieve many more milestones.” 

Ananthakrishnan said, “I would like to express my sincere thanks to the Executive Committee of OPPI for their valuable suggestions and support. It is my pleasure to welcome Mr Vivek Sehgal who takes over from me as the Director-General of OPPI. Vivek brings over three decades of rich experience across sectors, including Health, and I wish him all the very best.” 

Sehgal said, “I am delighted to be a part of the OPPI family and look forward to the opportunity to make a difference in patients’ lives. In my new role, I will work towards building OPPI’s commitment to fostering continuous research and development and enabling healthcare access for all. OPPI will continue to drive policy and advocacy discussions with the Government and endeavour to work together with various stakeholders on industry-related issues, to implement sustainable and patient-centric solutions.”

Read more on:
More news about: industrial talks | Published by Sudeep Soparkar | June - 21 - 2022

Last news about this category



We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology